Polymorphic repeat in AIB1 does not alter breast cancer risk - Wikidata - awgldk - TriplyDB

Polymorphic repeat in AIB1 does not alter breast cancer risk

Polymorphic repeat in AIB1 does not alter breast cancer risk

http://www.wikidata.org/entity/Q24791382

about

Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women Polymorphic repeat length in the AIB1 gene and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis of observational studies.Somatic instability of the DNA sequences encoding the polymorphic polyglutamine tract of the AIB1 gene.Cancer genetics of epigenetic genes.

P2860

Q24656096-9017AB7C-F99A-41CF-9E6E-2EC9C0A46253 Q24810265-84E18B7B-AFD3-412A-8228-C56A41E84E41 Q34618389-F6F152B7-10ED-4814-A91A-3C0BBA94BCE8 Q35441349-FE6BCDB5-440F-4053-954C-60A2E01D2E00 Q36871595-06541867-FDE7-42EC-BDC9-F0E61E902169

P2860

Polymorphic repeat in AIB1 does not alter breast cancer risk

http://www.wikidata.org/entity/Q24791382

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Polymorphic repeat in AIB1 does not alter breast cancer risk

@ast

Polymorphic repeat in AIB1 does not alter breast cancer risk

@en

Polymorphic repeat in AIB1 does not alter breast cancer risk

@nl

type

label

Polymorphic repeat in AIB1 does not alter breast cancer risk

@ast

Polymorphic repeat in AIB1 does not alter breast cancer risk

@en

Polymorphic repeat in AIB1 does not alter breast cancer risk

@nl

prefLabel

Polymorphic repeat in AIB1 does not alter breast cancer risk

@ast

Polymorphic repeat in AIB1 does not alter breast cancer risk

@en

Polymorphic repeat in AIB1 does not alter breast cancer risk

@nl

P1433

Q24791382-E95301E1-278D-490B-9750-CBCD8D93256C

P1476

Q24791382-74BB3973-14D0-405A-8A41-F0F284458373

P2093

Q24791382-37F64F1A-4144-4781-8B1A-9EDD6E5C2326

Q24791382-38080AFC-AE2E-40BC-8038-1C938C8FC25E

Q24791382-491A46CA-7F30-48B3-B3D7-DF02D65D49E6

Q24791382-E2C447AA-EB0A-42A4-987A-39294ADB585F

P2860

Q24791382-05643B52-1DB8-433A-A3DA-210760D1ABEF

Q24791382-1D3B1290-8C19-4ACA-95C3-BFD90A74D9FE

Q24791382-21C0B8D9-345F-49D3-99E2-977885493053

Q24791382-2E3A16FA-713D-4BEE-96FB-CBB84A474D74

Q24791382-5BCF35B5-A86C-4D5B-9882-58D9B670F85A

Q24791382-78868112-CE2E-4F26-9410-7D8201EA192F

Q24791382-7A1261DC-C1FE-4AF9-8BCE-5B889E5F6EC8

Q24791382-7F5F03BE-CF63-4292-866A-0D83896D3134

Q24791382-84418689-1CBE-4836-A147-80225384C944

Q24791382-87472A69-C060-4B68-BF11-0A441FED4970

P2888

Q24791382-232D04CA-2B79-4000-ACB0-7B701B21EAD6

P304

Q24791382-42E70D4C-F2AB-4374-B353-57FED18CED8B

P31

Q24791382-0D377A07-EFE5-4388-BDEC-255F59B2F717

P356

Q24791382-22A7489E-8761-4D86-9D43-1F4C71DFAD8A

P407

Q24791382-B954DE97-A7BB-4ADF-9121-01A754FBA468

P433

Q24791382-1EF1C699-CAD5-4D03-8391-7783925FDEA5

P478

Q24791382-67A4B4E5-B538-4175-9BC3-96DA690463BC

P50

Q24791382-26A7771A-33CD-4562-9728-00A2932CAEAD

Q24791382-2AA4287F-21E4-4170-8BAA-AF7A4B3EDF51

Q24791382-42F5261B-1EF3-4475-91E2-D05B0063D294

Q24791382-838D8BD9-A108-4990-83E1-461777599D30

P577

Q24791382-100052CD-7460-4A62-AB19-2D83E89CB379

P5875

Q24791382-26CB6273-3CA5-41D9-A246-17A5CFEEEF20

P6179

Q24791382-91B4455A-CAD8-479C-81D8-FEC4827201F2

P698

Q24791382-7DF0FA31-BB28-4066-9416-A166EA3C97D7

P932

Q24791382-1EB6C2B0-D992-4E2F-818D-109B8A87B3B9

P356

P1433

Breast Cancer Research

P1476

Polymorphic repeat in AIB1 does not alter breast cancer risk

@en

P2093

D Spiegelman

http://www.w3.org/2001/XMLSchema#string

F E Speizer

http://www.w3.org/2001/XMLSchema#string

S E Hankinson

http://www.w3.org/2001/XMLSchema#string

W C Willett

http://www.w3.org/2001/XMLSchema#string

P2860

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.

Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk

Regression analysis for correlated data.

Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.

Endogenous hormones and breast cancer risk.

Human familial and sporadic breast cancer: analysis of the coding regions of the 17 beta-hydroxysteroid dehydrogenase 2 gene (EDH17B2) using a single-strand conformation polymorphism assay.

Progesterone receptor gene polymorphism and risk for breast and ovarian cancer.

Polymorphic exonic CAG microsatellites in the gene amplified in breast cancer (AIB1 gene).

P2888

P304

378-385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR82

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

David J. Hunter

Christopher A. Haiman

P577

2000-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12269407

http://www.w3.org/2001/XMLSchema#string

P6179

1000612896

http://www.w3.org/2001/XMLSchema#string

P698

11056690

http://www.w3.org/2001/XMLSchema#string

P932

13920

http://www.w3.org/2001/XMLSchema#string